CRISPR/Cas9-Based Disease Modeling and Functional Correction of Interleukin 7 Receptor Alpha Severe Combined Immunodeficiency in T-Lymphocytes and Hematopoietic Stem Cells

Related articles

1. Targeting the gene encoding human T-cell leukemia virus type 1 basic zip factor via CRISPR/Cas9 potentially mitigates viral infection

   This article has 8 authors:

   1. Yuki Hashikura
   2. Misaki Izaki
   3. Kazumi Umeki
   4. Mami Azeta
   5. Katsumi Kawano
   6. Hiroo Hasegawa
   7. Mineki Saito
   8. Kunihiko Umekita

2. Autologous genome-edited hematopoietic stem cells correct Gaucher disease and establish a platform for clinical translation

   This article has 9 authors:

   1. Natalia Gomez-Ospina
   2. Luisa Pimentel Vera
   3. Marc Gastou
   4. Pasqualina Colella
   5. Jessica Arozqueta Basurto
   6. Allan Feng
   7. Yi Lin
   8. Xueheng Zhao
   9. Ying Sun

3. Integrating Human Genetics and Protective Genome Editing to Enable ADGRE2-Directed AML Therapy

   This article has 15 authors:

   1. Yonina Keschner
   2. Julia Etchin
   3. Mariana Silva
   4. Hannah Mager
   5. Hillary Hoyt
   6. Juliana Xavier-Ferrucio
   7. Nathan Manalo
   8. Amanda Halfond
   9. Huan Qiu
   10. Ruijia Wang
   11. Michelle I. Lin
   12. Huanying Gary Ge
   13. Julian Scherer
   14. Tirtha Chakraborty
   15. John R. Lydeard